Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Key Factors to Evaluate Before Investing in ISRG

Shares of Health Care sector company Intuitive Surgical moved -0.4% today, and are now trading at a price of $472.31. The Large-Cap stock's daily volume was 214,084 compared to its average volume of 1,896,909. The S&P 500 index returned a 0.0% performance.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company is based in Sunnyvale and has 15,638 full time employees. Its market capitalization is $169,312,272,384.

27 analysts are following Intuitive Surgical and have set target prices ranging from $350.0 to $685.0 per share. On average, they have given the company a rating of buy. At today's prices, ISRG is trading -18.86% away from its average analyst target price of $582.1 per share.

Over the last year, ISRG shares have gone down by -1.6%, which represents a difference of -17.3% when compared to the S&P 500. The stock's 52 week high is $616.0 per share and its 52 week low is $425.0. With average free cash flows of $1.18 Billion that have been growing at an average rate of 2.4% over the last 5 years, Intuitive Surgical declining stock performance may not be reflective of the quality of its underlying business.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2024 2,415,000 1,111,200 1,303,800 73.93
2023 1,813,800 1,064,200 749,600 -21.79
2022 1,490,800 532,400 958,400 -45.23
2021 2,089,400 339,500 1,749,900 53.06
2020 1,484,800 341,500 1,143,300 -2.5
2019 1,598,200 425,600 1,172,600
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS